Press Release

UAE Cardiovascular Devices Market to grow with a CAGR of 5.11%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Cardiovascular Devices Market.


According to TechSci Research report, “UAE Cardiovascular Devices Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Cardiovascular Devices Market has valued at USD 0.59 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.11% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

The growing aging population is a significant driver of the demand for cardiovascular devices. As the population ages, there is an increased prevalence of cardiovascular diseases and related conditions. Cardiovascular devices play a crucial role in the diagnosis, treatment, and management of these conditions. Aging is a major risk factor for cardiovascular diseases, and the elderly population often experiences a higher incidence of conditions such as coronary artery disease, heart failure, and atrial fibrillation. The rise in cardiovascular diseases among older individuals drives the demand for diagnostic devices, monitoring solutions, and therapeutic interventions. The aging process is associated with an increased prevalence of chronic conditions such as hypertension, diabetes, and hyperlipidemia, which are major contributors to cardiovascular diseases. Cardiovascular devices, including blood pressure monitors, glucose monitors, and lipid management tools, are in demand to manage these chronic conditions effectively.

The aging population often requires continuous monitoring of cardiovascular health to detect and prevent potential issues. Wearable devices, implantable monitors, and home-based monitoring tools are increasingly sought after by older individuals who wish to actively manage their heart health. Aging is associated with an increased risk of conditions such as aortic stenosis, valvular heart diseases, and vascular issues. Advanced diagnostic imaging devices, including echocardiography and vascular imaging systems, are essential for accurate diagnosis and treatment planning in the elderly population.


Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Cardiovascular Devices Market.”


In June 2022, A groundbreaking initiative by health tech pioneers and cardiologists operating under the banner of UPOlife has resulted in the development of a revolutionary product – the UPOlife Wearable Biosensor Patch. This innovative solution is designed to effectively address challenges arising from the pandemic by enabling users to remotely assess their heart health and overall wellness. The UPOlife Wearable Biosensor Patch, a disposable medical-grade heart health screening device, boasts internal data storage capabilities for a comprehensive 7-day monitoring period. Notably, the patch eliminates the need for additional applications and doctor visits for application. Patients can seamlessly integrate vital signs monitoring into their daily routines, as the device records a two-channel electrocardiogram (ECG) signal, heart rate, and heart rate variability. Subsequently, the UPOlife team leverages this data to generate a comprehensive heart health and wellness report, with all findings validated by a professional cardiologist.

Insurance coverage and reimbursement issues represent a significant challenge in the UAE Cardiovascular Devices Market. The extent of insurance coverage for cardiovascular procedures and devices may vary, leading to disparities in access to advanced cardiovascular care. Patients without comprehensive insurance coverage may face barriers to obtaining certain cardiovascular devices and treatments. Even with insurance coverage, patients may still incur high out-of-pocket costs for cardiovascular devices and procedures. Copayments, deductibles, and co-insurance requirements can create financial burdens, affecting patient affordability. Reimbursement policies for cardiovascular procedures and devices may differ among insurers and healthcare providers. Inconsistent reimbursement standards can lead to uncertainties for healthcare providers and impact their willingness to adopt certain technologies.


UAE Cardiovascular Devices Market is segmented based on Type, Application, End User, and by region.  


Based on the Application, UAE Cardiovascular Devices Market is segmented into Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others. Heart failure is a medical condition that occurs when the heart is unable to pump blood effectively, leading to inadequate circulation and delivery of oxygen and nutrients to the body's tissues and organs. Despite its name, heart failure does not mean that the heart has stopped working; rather, it signifies a weakening of the heart's ability to meet the body's demands. In systolic heart failure, the heart's pumping function is weakened. The left ventricle, the heart's main pumping chamber, has difficulty contracting with enough force to propel blood into the circulation. Diastolic heart failure, also known as heart failure with preserved ejection fraction (HFpEF), occurs when the heart becomes stiff and has difficulty relaxing between beats. This stiffness affects the heart's ability to fill properly, reducing the amount of blood that can be pumped out.

Based on Region, Abu Dhabi region held the largest share in the UAE Cardiovascular Devices Market. The population density in Abu Dhabi, being one of the largest emirates, may contribute to a higher demand for healthcare services, including cardiovascular care. The concentration of population and healthcare facilities can make Abu Dhabi a strategic market for cardiovascular devices. The economic strength of Abu Dhabi, driven by factors such as oil wealth and diversified investments, can contribute to a robust healthcare sector. Patients in Abu Dhabi may have the financial means to access advanced cardiovascular care and invest in cutting-edge medical technologies. Abu Dhabi's efforts to attract medical tourists seeking high-quality healthcare services could influence the demand for advanced cardiovascular devices. Patients from both within and outside the UAE may choose Abu Dhabi for cardiovascular treatments, driving market demand.

Some of the major companies operating in the UAE Cardiovascular Devices Market include:

  • Medtronic Meta FZ-LLC
  • Abbott Laboratories S.A.
  • Terumo UAE
  • Philips Healthcare UAE
  • Life Companion
  • Vasmed UAE
  • Life Mate Medical Equipment Trading LLC

 

Download  free Sample Report

Customers can also request 10% free customization on this report.


“Certain areas, particularly in Dubai, are projected to exert significant demand for Cardiovascular Devices. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Cardiovascular Devices Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Cardiovascular Devices Market by Type (Diagnostic & Monitoring Devices {ECG, Holter Monitors, Implantable Loop Recorders, Event Monitors, Others}, Surgical Devices {Pacemakers, Defibrillators, Stents, Valves, Other}), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Cardiovascular Devices Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Cardiovascular Devices Market.

Contact

Mr. Ken Mathews

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602 

Email: [email protected]

Website: https://www.techsciresearch.com

Relevant News